Analyst Reco. Valneva

Equities

VLA

FR0004056851

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:55:00 16/01/2026 GMT			5-day change	1st Jan Change
4.388 ^EUR	+2.81%		+3.10%	+18.02%

01-06	Valneva Surges on Positive Broker Comments
01-06	Stifel Raises Price Target for Valneva

Analyst Reco.

01-06	Valneva Surges on Positive Broker Comments
01-06	Stifel Raises Price Target for Valneva
11-20	Stifel Reiterates Buy Recommendation on Valneva
11-04	Valneva SE Announces Positive Results of Its Phase 1 Clinical Trial Investigating the Safety and Immunogenicity of VLA1601	CI
03/09/25	Valneva publishes positive data for its Lyme disease vaccine candidate, stock rises	RE
26/08/25	Valneva: Stifel Adjusts Price Target Following FDA Suspension of Ixchiq License
26/08/25	VALNEVA : Stifel adjusts target price
12/08/25	VALNEVA : Oddo BHF confirms 'outperform' rating
14/07/25	Valneva Shares Surge After EMA Lifts Restriction on Chikungunya Vaccine	RE
13/08/24	Valneva: share price up, broker's analysis
13/08/24	VALNEVA : Oddo BHF confirms its recommendation on the stock
24/06/24	Valneva rises after Canadian approval for its chikungunya vaccine	RE
05/02/24	VALNEVA : Oddo BHF confirms its recommendation on the stock
02/01/24	VALNEVA : Oddo BHF remains positive
10/11/23	HC Wainwright Adjusts Price Target on Valneva SE to $26 From $22, Maintains Buy Rating	MT
08/11/23	Valneva: share price in demand on eve of earnings release
14/08/23	Valneva falls after FDA postpones review date for its Chikungunya vaccine	RE
16/06/23	Valneva: up sharply after positive analysis
16/06/23	VALNEVA : one of Oddo BHF's favorite European biotechs
01/10/22	HC Wainwright Adjusts Price Target on Valneva to $27 From $32, Reiterates Buy Rating	MT
23/09/22	Goldman Sachs Downgrades Valneva to Neutral From Buy	MT
22/08/22	HC Wainwright Trims Price Target on Valneva SE to $32 From $34, Reiterates Buy Rating	MT
03/08/22	HC Wainwright Starts Valneva at Buy With $34 Price Target	MT
28/07/22	Kepler Cheuvreux Downgrades Valneva to Hold From Buy	MT
23/06/22	European stocks skid on gloomy business activity data, German energy troubles	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Valneva: the return of biotech euphoria?

August 13, 2025 at 08:07 am